Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis

OBJECTIVE: Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE). The pathogenesis is incompletely understood and diagnostic biomarkers are scarce. We investigated interleukin (IL) 16 as a potential biomarker for LN in a well-characterised cohort of patients with SLE....

Descripción completa

Detalles Bibliográficos
Autores principales: Häyry, Aliisa, Faustini, Francesca, Zickert, Agneta, Larsson, Anders, Niewold, Timothy B, Svenungsson, Elisabet, Oke, Vilija, Gunnarsson, Iva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Lupus Nephritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476119/
https://www.ncbi.nlm.nih.gov/pubmed/36104119
http://dx.doi.org/10.1136/lupus-2022-000744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476119/
https://www.ncbi.nlm.nih.gov/pubmed/36104119
http://dx.doi.org/10.1136/lupus-2022-000744

Ejemplares similares